Literature DB >> 26042815

Sexually transmitted diseases treatment guidelines, 2015.

Kimberly A Workowski, Gail A Bolan.   

Abstract

These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 30-May 2, 2013. The information in this report updates the Sexually Transmitted Diseases Treatment Guidelines, 2010 (MMWR Recomm Rep 2010;59 [No. RR-12]). These updated guidelines discuss 1) alternative treatment regimens for Neisseria gonorrhoeae; 2) the use of nucleic acid amplification tests for the diagnosis of trichomoniasis; 3) alternative treatment options for genital warts; 4) the role of Mycoplasma genitalium in urethritis/cervicitis and treatment-related implications; 5) updated HPV vaccine recommendations and counseling messages; 6) the management of persons who are transgender; 7) annual testing for hepatitis C in persons with HIV infection; 8) updated recommendations for diagnostic evaluation of urethritis; and 9) retesting to detect repeat infection. Physicians and other health-care providers can use these guidelines to assist in the prevention and treatment of STDs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26042815      PMCID: PMC5885289     

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  852 in total

1.  Chlamydia trachomatis persistence in vitro: an overview.

Authors:  Priscilla B Wyrick
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

2.  The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening.

Authors:  Irving E Salit; Alice Lytwyn; Janet Raboud; Marie Sano; Sylvia Chong; Christina Diong; William Chapman; James B Mahony; Jill Tinmouth
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

3.  A behavioural intervention to reduce persistence of bacterial vaginosis among women who report sex with women: results of a randomised trial.

Authors:  Jeanne M Marrazzo; Katherine K Thomas; Kathleen Ringwood
Journal:  Sex Transm Infect       Date:  2011-06-08       Impact factor: 3.519

4.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

Authors:  Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

5.  Azithromycin in the treatment of sexually transmitted disease.

Authors:  O Steingrimsson; J H Olafsson; H Thorarinsson; R W Ryan; R B Johnson; R C Tilton
Journal:  J Antimicrob Chemother       Date:  1990-01       Impact factor: 5.790

6.  Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial.

Authors:  Kirsten J McCaffery; Les Irwig; Robin Turner; Siew Foong Chan; Petra Macaskill; Mary Lewicka; Judith Clarke; Edith Weisberg; Alex Barratt
Journal:  BMJ       Date:  2010-02-23

7.  A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.

Authors:  Jennifer E Balkus; Barbra A Richardson; Vernon Mochache; Vrasha Chohan; Jeannie D Chan; Linnet Masese; Juma Shafi; Jeanne Marrazzo; Carey Farquhar; R Scott McClelland
Journal:  Sex Transm Dis       Date:  2013-06       Impact factor: 2.830

8.  Sexual behaviour and risk reduction strategies among a multinational sample of women who have sex with women.

Authors:  Vanessa Schick; Joshua G Rosenberger; Debby Herbenick; Michael Reece
Journal:  Sex Transm Infect       Date:  2012-05-05       Impact factor: 3.519

9.  Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study.

Authors:  Pippa Oakeshott; Adamma Aghaizu; Phillip Hay; Fiona Reid; Sally Kerry; Helen Atherton; Ian Simms; David Taylor-Robinson; Birthe Dohn; Jorgen S Jensen
Journal:  Clin Infect Dis       Date:  2010-10-13       Impact factor: 9.079

10.  Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis.

Authors:  Michael J Ferris; Alicia Masztal; Kenneth E Aldridge; J Dennis Fortenberry; Paul L Fidel; David H Martin
Journal:  BMC Infect Dis       Date:  2004-02-13       Impact factor: 3.090

View more
  961 in total

1.  Optimal Timing for Trichomonas vaginalis Test of Cure Using Nucleic Acid Amplification Testing.

Authors:  Megan Clare Craig-Kuhn; Charleigh Granade; Christina A Muzny; Barbara Van Der Pol; Rebecca Lillis; Stephanie N Taylor; Norine Schmidt; David H Martin; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2019-05       Impact factor: 2.830

2.  Levels of Mycoplasma genitalium Antimicrobial Resistance Differ by Both Region and Gender in the State of Queensland, Australia: Implications for Treatment Guidelines.

Authors:  E L Sweeney; E Trembizki; C Bletchly; C S Bradshaw; A Menon; F Francis; J Langton-Lockton; G R Nimmo; D M Whiley
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

3.  A Comparative Study of Liquid Nitrogen Cryotherapy as Monotherapy versus in Combination with Podophyllin in the Treatment of Condyloma Acuminata.

Authors:  Nidhi Sharma; Sanjeev Sharma; Chetna Singhal
Journal:  J Clin Diagn Res       Date:  2017-03-01

4.  Transient aortitis documented by positron emission tomography in a case series of men and transgender women infected with syphilis.

Authors:  Dvora Joseph Davey; Noah Kojima; Kelika A Konda; Pawan Gupta; Segundo R Leon; Gino M Calvo; Carlos F Caceres; Jeffrey D Klausner
Journal:  Sex Transm Infect       Date:  2017-09-02       Impact factor: 3.519

5.  Community Colleges: Rethinking STD Prevention for the Nontraditional College Campus.

Authors:  Melissa A Habel; Jeffrey S Becasen; Rachel Kachur; Heather Eastman-Mueller; Patricia J Dittus
Journal:  Community Coll J Res Pract       Date:  2016-09

6.  Prevalence and Correlates of Trichomonas vaginalis Infection Among Men and Women in the United States.

Authors:  Eshan U Patel; Charlotte A Gaydos; Zoe R Packman; Thomas C Quinn; Aaron A R Tobian
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

7.  Cost-Effectiveness of Opt-Out Chlamydia Testing for High-Risk Young Women in the U.S.

Authors:  Kwame Owusu-Edusei; Karen W Hoover; Thomas L Gift
Journal:  Am J Prev Med       Date:  2016-03-04       Impact factor: 5.043

8.  Gentamicin as an alternative treatment for gonorrhoea.

Authors:  Robert D Kirkcaldy; Kimberly A Workowski
Journal:  Lancet       Date:  2019-05-02       Impact factor: 79.321

Review 9.  Antibiotic treatment for the sexual partners of women with bacterial vaginosis.

Authors:  Jairo Amaya-Guio; David Andres Viveros-Carreño; Eloisa Mercedes Sierra-Barrios; Mercy Yolima Martinez-Velasquez; Carlos F Grillo-Ardila
Journal:  Cochrane Database Syst Rev       Date:  2016-10-01

10.  Gonococcal cellulitis: an (un)friendly bite.

Authors:  Amos Lal; Alwyn Rapose
Journal:  Infection       Date:  2018-03-16       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.